In 2020, Blue KC expanded its availability of prescription formularies (also called drug lists) for large group clients from one option to two, and the results were remarkable.
Client adoption of the Premium formulary started off strong in 2021. The cumulative number of members using the Premium Formulary has more than tripled since initially available.
Premium formulary growth 2021-2022
|Year||Members Using Premium Formulary|
The Premium formulary is an option for large group clients wanting access to a formulary that manages traditional, nonspecialty drug costs without compromising clinical outcomes. In many cases it saved early adopters nearly 10% per member per month on their plan’s traditional drug spend. Overall, members saved on drug costs without rigorous additional step therapies, prior authorizations, or other invasive utilization management strategies.
Members transitioning to the Premium formulary will receive communications about the change, potential disruptions to their drug therapies, and clinically appropriate and cost-effective alternatives. Blue KC will continue to make quarterly updates to the Premium formulary and will send subsequent member communications about those changes and appropriate alternatives to affected members.
Blue KC is working with clients to provide strong, accurate, and even granular analysis of the potential disruption and savings. Transparent analysis coupled with our proactive communication strategy is providing a strong utilization management strategy that has real impact in the short and long term without compromising the member experience or access to the products necessary to manage chronic conditions.
Transition your clients to the Premium formulary
Human resource departments across Kansas City have continued to share positive feedback about their transitions to the Premium formulary and the financial impact on their traditional, nonspecialty drug costs. Start the conversation with your clients about transitioning to the Premium formulary. Contact your Blue KC representative for strategies, materials, and talking points.